A detailed history of Key F Inancial Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Key F Inancial Inc holds 290 shares of VRTX stock, worth $130,781. This represents 0.03% of its overall portfolio holdings.

Number of Shares
290
Previous 301 3.65%
Holding current value
$130,781
Previous $141,000 4.96%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$460.0 - $505.78 $5,060 - $5,563
-11 Reduced 3.65%
290 $134,000
Q2 2024

Jul 29, 2024

BUY
$392.81 - $485.53 $98,595 - $121,868
251 Added 502.0%
301 $141,000
Q2 2023

Jul 28, 2023

BUY
$314.42 - $351.91 $10,061 - $11,261
32 Added 177.78%
50 $17,000
Q4 2021

Jan 19, 2022

BUY
$177.01 - $223.45 $3,186 - $4,022
18 New
18 $4,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.